Idiopathic Macular Telangiectasia Type 1 with Ruptured Retinal Arterial Macroaneurysm Post Intravitreal Bevacizumab.

Abstract

A 50-year-old Indian male presented with defective vision in the right eye for 6 months. He was diagnosed to have idiopathic macular telangiectasia (IMT) type 1 associated with diffuse macular edema and multiple retinal arterial macroaneurysms (RAM). Intravitreal bevacizumab was administered for the treatment of macular edema, following which there was a rupture of a preexisting RAM with multilevel retinal hemorrhages. The hemorrhage gradually resolved over time with foveal thinning noted at last visit. We report this case for the rare occurrence of IMT type 1 and also the possibly associated rupture of RAM post intravitreal bevacizumab injection.

• Authors: Chinmay P Nakhwa, Manavi D Sindal
• Journal: Middle East African journal of ophthalmology (Middle East Afr J Ophthalmol) 2015 Jul-Sep Vol. 22 Issue 3 Pg. 396-8 ISSN: 0975-1599 [Electronic] India
• PMID: 26180485 (Publication Type: Case Reports, Journal Article)

Chemical References

• Angiogenesis Inhibitors
• Antibodies, Monoclonal, Humanized
• VEGFA protein, human
• Vascular Endothelial Growth Factor A
• Bevacizumab

Topics

• Aneurysm, Ruptured (diagnosis, etiology)
• Angiogenesis Inhibitors (therapeutic use)
• Antibodies, Monoclonal, Humanized (therapeutic use)
• Bevacizumab
• Blindness (etiology)
• Fluorescein Angiography
• Humans
• Intravitreal Injections
• Macular Edema (drug therapy, etiology)
• Male
• Middle Aged
• Postoperative Complications
• Retinal Artery (pathology)
• Retinal Hemorrhage (diagnosis, etiology)
• Retinal Telangiectasis (diagnosis, etiology)
• Tomography, Optical Coherence
• Vascular Endothelial Growth Factor A (antagonists & inhibitors)
• Visual Acuity (physiology)